Bayer CropScience Q2 FY20 earnings call: Revenue & Margins
Q2 FY20 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #15 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
Bayer CropScience Ltd Q2 FY20 key numbers
- Revenue
- Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase.
As stated in Bayer CropScience Ltd's Q2 FY20 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.
Based on Bayer CropScience Ltd's Q2 FY20 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20). EBITDA for Q3 2019: €1,492 million, up 9.3% year-on-year (YoY) - Operating margin: 21.8%, up 51 basis points YoY - Profit (PAT) for Q3 2019: €1,010 million, up 41.7% YoY
From Bayer CropScience Ltd's Q2 FY20 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20).
- H1 Revenue from Operations: ₹22,967 million, +7.3% year-on-year growth (Page 20).
- Q2 Profit Before Exceptional Items and Tax: ₹4,978 million, +1.3% year-on-year (Page 20).
- H1 Profit Before Exceptional Items and Tax: ₹4,913 million, +22.2% year-on-year (Page 20).
- Sept YTD EverGol Xtend & Velum Prime sales: 17 KL with a full-year estimate of 23 KL (Page 24).
- Arize business milestone: volume achieved 15,570 MT (Page 23).
2 more points from Bayer CropScience Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
See what Bayer CropScience Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Bayer CropScience Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bayer CropScience's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Aries Agro (Q2 FY20)
EBITDA: INR 450 million (H1-FY20) with margin 16.96% (FY19 full year). Key concall takeaways from Aries Agro Ltd's Q2 FY20 earnings call — and how it ranks…
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Insecticides IndiaGood growth2
- Anya Polytech &Good growth1
- Madhya Bharat Agro ProductsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Bayer CropScience Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Bayer CropScience Ltd Q2 FY20 results?
Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20). EBITDA for Q3 2019: €1,492 million, up 9.3% year-on-year (YoY) - Operating margin: 21.8%, up 51 basis points YoY - Profit (PAT) for Q3 2019: €1,010 million, up 41.7% YoY
What is Bayer CropScience Ltd share price analysis?
Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 23.2 with a market cap of ₹16,986 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
